Bruce Bissonnette to Colorectal Neoplasms
This is a "connection" page, showing publications Bruce Bissonnette has written about Colorectal Neoplasms.
Connection Strength
0.809
-
Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions. Inflamm Bowel Dis. 2013 Mar; 19(3):461-70.
Score: 0.244
-
Ursodeoxycholic acid and chemoprevention of colorectal cancer. Gastroenterol Clin Biol. 2010 Oct; 34(10):516-22.
Score: 0.203
-
T-oligo as an anticancer agent in colorectal cancer. Biochem Biophys Res Commun. 2014 Apr 04; 446(2):596-601.
Score: 0.065
-
Estrogen receptor-ß protects against colitis-associated neoplasia in mice. Int J Cancer. 2012 Dec 01; 131(11):2553-61.
Score: 0.058
-
Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer. Int J Oncol. 2012 Jun; 40(6):1970-6.
Score: 0.057
-
Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia. Am J Pathol. 2011 Sep; 179(3):1494-503.
Score: 0.054
-
Upregulation of glycogen synthase kinase 3ß in human colorectal adenocarcinomas correlates with accumulation of CTNNB1. Clin Colorectal Cancer. 2011 Mar 01; 10(1):30-6.
Score: 0.053
-
Polyethylene glycol-mediated colorectal cancer chemoprevention: roles of epidermal growth factor receptor and Snail. Mol Cancer Ther. 2008 Sep; 7(9):3103-11.
Score: 0.045
-
Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Int J Cancer. 2002 Oct 01; 101(4):301-10.
Score: 0.030